Propanc BiopharmaPPCB
13F holders, Q3 2025 (September 30)3holders
$1.70avg. 13F price*
At the end of Q3 2025, 3 institutions reported holding Propanc Biopharma Inc. (PPCB) in their 13F filings. The largest holders were Marex Group Ltd ($120K), Virtu Financial LLC ($71K) and Morgan Stanley ($2).
- Company
- Propanc Biopharma Inc.
- CUSIP
- 74346N701
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $191K |
| Exits | 0 | $0 |
Ownership 3 holders
| Marex Group Ltd | 0.00% | New | 70,429 | $120K |
| Virtu Financial LLC | 0.00% | New | 41,677 | $71K |
| Morgan Stanley | 0.00% | New | 1 | $2 |
"% of holder's portfolio" is PPCB's weight in each manager's 13F, not the share of Propanc Biopharma Inc. the manager owns.